B

BMC Medical Co Ltd
SZSE:301367

Watchlist Manager
BMC Medical Co Ltd
SZSE:301367
Watchlist
Price: 67.98 CNY 0.67% Market Closed
Market Cap: 6.1B CNY
Have any thoughts about
BMC Medical Co Ltd?
Write Note

BMC Medical Co Ltd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BMC Medical Co Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
B
BMC Medical Co Ltd
SZSE:301367
Free Cash Flow
ÂĄ127m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Free Cash Flow
ÂĄ487m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Free Cash Flow
ÂĄ1.7B
CAGR 3-Years
42%
CAGR 5-Years
67%
CAGR 10-Years
49%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Free Cash Flow
ÂĄ12.2B
CAGR 3-Years
17%
CAGR 5-Years
25%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Free Cash Flow
ÂĄ872.5m
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Free Cash Flow
-ÂĄ943.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BMC Medical Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Health Care

BMC Medical Co. Ltd. principally engages in the research, development, production, and sale of medical equipment and consumable products in the field of respiratory health. The company is headquartered in Beijing, Beijing and currently employs 843 full-time employees. The company went IPO on 2022-11-01. The firm's products mainly include non-invasive home ventilators, ventilation masks, sleep monitors and high-flow humidified oxygen therapy devices. The firm also provides respiratory health chronic disease management services. The firm focuses on the treatment of patients with sleep apnea-hypopnea syndrome (SAHS), mainly obstructive sleep apnea syndrome (OSA), as well as patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD), providing a full-cycle and multi-scenario overall solution for treatment services.

Intrinsic Value
63.07 CNY
Overvaluation 7%
Intrinsic Value
Price
B

See Also

What is BMC Medical Co Ltd's Free Cash Flow?
Free Cash Flow
127m CNY

Based on the financial report for Dec 31, 2023, BMC Medical Co Ltd's Free Cash Flow amounts to 127m CNY.

What is BMC Medical Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-20%

Over the last year, the Free Cash Flow growth was -64%. The average annual Free Cash Flow growth rates for BMC Medical Co Ltd have been -20% over the past three years .

Back to Top